5 patents
Utility
Peptide conjugates
25 Jul 23
Methods and compositions related to the selective, specific disruption of multiple ligand-receptor signaling interactions, such as ligand-receptor interactions implicated in disease, are disclosed.
Yutaka Tagaya, Nazli Azimi
Filed: 4 Sep 20
Utility
Selective peptide antagonists
4 Oct 22
Methods and compositions related to the selective, specific disruption of multiple ligand-receptor signaling interactions, such as ligand-receptor interactions implicated in disease, are disclosed.
Nazli Azimi, Yutaka Tagaya
Filed: 28 Oct 20
Utility
Modulating gamma-c-cytokine activity
2 Aug 22
Embodiments relate to peptide antagonists of γc-family cytokines, which is associated with important human diseases, such as leukemia, autoimmune diseases, collagen diseases, diabetes mellitus, skin diseases, degenerative neuronal diseases and graft-versus-host disease (GvHD).
Nazli Azimi
Filed: 6 Oct 16
Utility
Selective peptide antagonists
30 Nov 20
Methods and compositions related to the selective, specific disruption of multiple ligand-receptor signaling interactions, such as ligand-receptor interactions implicated in disease, are disclosed.
Nazli Azimi, Yutaka Tagaya
Filed: 26 Apr 18
Utility
Peptide conjugates
19 Oct 20
Methods and compositions related to the selective, specific disruption of multiple ligand-receptor signaling interactions, such as ligand-receptor interactions implicated in disease, are disclosed.
Yutaka Tagaya, Nazli Azimi
Filed: 18 Apr 18
- Prev
- 1
- Next
Patents are sorted by USPTO publication date, most recent first